fiprotec spray, 2,5 mg/ml
beaphar b.v., drostenkamp 3, 8101 bx raalte, nizozemska - fipronil - sprej za kožu, otopina - ektoparaziticidi za lokalnu upotrebu, uklj. insekticide - pasa, mačaka
fiprotec spray, 2,5 mg/ml
beaphar b.v., drostenkamp 3, 8101 bx, raalte, nizozemska - fipronil - sprej za kožu, otopina - pasa, mačaka
kuprovent n
galenika crna gora d.o.o. za proizvodnju i promet farmaceutskih proizvoda - dentalna medicinska sredstva
bellune 35 obložene tablete
pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb - cyproteronum, ethinylestradiolum - obložena tableta - 2 mg + 0,035 mg - urbroj: jedna obložena tableta sadrži 2 mg ciproteronacetata i 0,035 mg etinilestradiola
nalgesin forte 550 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - naproksen - filmom obložena tableta - 550 mg/1 tableta - 1 filmom obložena tableta sadrži: 550 mg naproksennatrijuma (što odgovara 502 mg naproksena)
nalgesin s 275 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - naproksen - filmom obložena tableta - 275 mg/1 tableta - 1 filmom obložena tableta sadrži: 275 mg (što odgovara 251 mg naproksena) naproksennatrijuma
nalgesin s 275 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - naproksen - filmom obložena tableta - 275 mg/1 tableta - 1 filmom obložena tableta sadrži: 275 mg (što odgovara 251 mg naproksena) naproksennatrijuma
nalgesin forte 550 mg/1 tableta filmom obložena tableta
krka farma d.o.o. sarajevo - naproksen - filmom obložena tableta - 550 mg/1 tableta - 1 filmom obložena tableta sadrži: 550 mg naproksen natrijuma (što odgovara 502 mg naproksena)
flebogamma dif (previously flebogammadif)
instituto grifols s.a. - imunoglobulina osoba normalan - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - imuni serumi i homologna, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.
hizentra
csl behring gmbh - ljudski normalni imunoglobulin (scig) - sindromi imunološke manjkavosti - imuni serumi i homologna, - replacement therapy in adults, children and adolescents (0-18 years) in:- primary immunodeficiency syndromes with impaired antibody production (see section 4. - secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of.